One speaker at the ACIP meeting worried about a perception of inferiority if the single-dose Janssen vaccine is destined for places where people have had access issues. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
